Old Web
English
Sign In
Acemap
>
Paper
>
Editorial by US Food and Drug Administration Attorney Fails to Address Core and Ongoing Issues Seen With Vasopressin Market
Editorial by US Food and Drug Administration Attorney Fails to Address Core and Ongoing Issues Seen With Vasopressin Market
2019
Philip J. Almeter
Eugene A. Hessel
Jonathan A. Labuhn
Peter E. Morris
Keywords:
Anesthesia
Drug
Vasopressin
Intensive care medicine
Medicine
food and drug administration
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]